|
1
|
Maron BJ, Towbin JA, Thiene G,
Antzelevitch C, Corrado D, Arnett D, Moss AJ, Seidman CE, Young JB;
American Heart Association; et al Contemporary definitions and
classification of the cardiomyopathies; An American Heart
Association Scientific Statement from the Council on Clinical
Cardiology, Heart Failure and Transplantation Committee; Quality of
Care and Outcomes Research and Functional Genomics and
Translational Biology Interdisciplinary Working Groups; Council on
Epidemiology and Prevention: Circulation. 113:1807–1816. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Garcia-Pavia P, Cobo-Marcos M,
Guzzo-Merello G, Gomez-Bueno M, Bornstein B, Lara-Pezzi E, Segovia
J and Alonso-Pulpon L: Genetics in dilated cardiomyopathy. Biomark
Med. 7:517–533. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Huo J, Ma A, Bai L and Liu P: A
novel mutation of the LMNA gene in a family with dilated
cardiomyopathy, conduction system disease, and sudden cardiac death
of young females. Mol Cell Biochem. 382:307–311. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
McNally EM, Golbus JR and Puckelwartz MJ:
Genetic mutations and mechanisms in dilated cardiomyopathy. J Clin
Invest. 123:19–26. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Agrawal PB, Pierson CR, Joshi M, Liu X,
Ravenscroft G, Moghadaszadeh B, Talabere T, Viola M, Swanson LC,
Haliloğlu G, et al: SPEG interacts with myotubularin, and its
deficiency causes centronuclear myopathy with dilated
cardio-myopathy. Am J Hum Genet. 95:218–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Arndt AK, Schafer S, Drenckhahn JD, Sabeh
MK, Plovie ER, Caliebe A, Klopocki E, Musso G, Werdich AA, Kalwa H,
et al: Fine mapping of the 1p36 deletion syndrome identifies
mutation of PRDM16 as a cause of cardiomyopathy. Am J Hum Genet.
93:67–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Haas J, Frese KS, Peil B, Kloos W, Keller
A, Nietsch R, Feng Z, Müller S, Kayvanpour E, Vogel B, et al: Atlas
of the clinical genetics of human dilated cardiomyopathy. Eur Heart
J. 36:1123–1135a. 2015. View Article : Google Scholar
|
|
8
|
Reinstein E, Orvin K, Tayeb-Fligelman E,
Stiebel-Kalish H, Tzur S, Pimienta AL, Bazak L, Bengal T, Cohen L,
Gaton DD, et al: Mutations in TAX1BP3 cause dilated cardiomyopathy
with septooptic dysplasia. Hum Mutat. 36:439–442. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wahbi K, Béhin A, Bécane HM, Leturcq F,
Cossée M, Laforêt P, Stojkovic T, Carlier P, Toussaint M, Gaxotte
V, et al: Dilated cardiomyopathy in patients with mutations in
anoctamin 5. Int J Cardiol. 168:76–79. 2013. View Article : Google Scholar
|
|
10
|
Flack E and Kannankeril PJ: The genetics
of dilated cardiomyopathy. Heart Rhythm. 9:397–398. 2012.
View Article : Google Scholar
|
|
11
|
Pashmforoush M, Lu JT, Chen H, Amand TS,
Kondo R, Pradervand S, Evans SM, Clark B, Feramisco JR, Giles W, et
al: Nkx2-5 pathways and congenital heart disease; loss of
ventricular myocyte lineage specification leads to progressive
cardiomyopathy and complete heart block. Cell. 117:373–386. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prall OW, Menon MK, Solloway MJ, Watanabe
Y, Zaffran S, Bajolle F, Biben C, McBride JJ, Robertson BR, Chaulet
H, et al: An Nkx2-5/Bmp2/Smad1 negative feedback loop controls
heart progenitor specification and proliferation. Cell.
128:947–959. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pikkarainen S, Tokola H, Kerkelä R and
Ruskoaho H: GATA transcription factors in the developing and adult
heart. Cardiovasc Res. 63:196–207. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Greulich F, Rudat C and Kispert A:
Mechanisms of T-box gene function in the developing heart.
Cardiovasc Res. 91:212–222. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Oka T, Xu J and Molkentin JD:
Re-employment of developmental transcription factors in adult heart
disease. Semin Cell Dev Biol. 18:117–131. 2007. View Article : Google Scholar
|
|
16
|
Song K, Nam YJ, Luo X, Qi X, Tan W, Huang
GN, Acharya A, Smith CL, Tallquist MD, Neilson EG, et al: Heart
repair by reprogramming non-myocytes with cardiac transcription
factors. Nature. 485:599–604. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
McCulley DJ and Black BL: Transcription
factor pathways and congenital heart disease. Curr Top Dev Biol.
100:253–277. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Stennard FA, Costa MW, Elliott DA, Rankin
S, Haast SJ, Lai D, McDonald LP, Niederreither K, Dolle P, Bruneau
BG, et al: Cardiac T-box factor Tbx20 directly interacts with
Nkx2-5, GATA4, and GATA5 in regulation of gene expression in the
developing heart. Dev Biol. 262:206–224. 2003. View Article : Google Scholar
|
|
19
|
Schott JJ, Benson DW, Basson CT, Pease W,
Silberbach GM, Moak JP, Maron BJ, Seidman CE and Seidman JG:
Congenital heart disease caused by mutations in the transcription
factor NKX2-5. Science. 281:108–111. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qu XK, Qiu XB, Yuan F, Wang J, Zhao CM,
Liu XY, Zhang XL, Li RG, Xu YJ, Hou XM, et al: A novel NKX2.5
loss-of-function mutation associated with congenital bicuspid
aortic valve. Am J Cardiol. 114:1891–1895. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Garg V, Kathiriya IS, Barnes R,
Schluterman MK, King IN, Butler CA, Rothrock CR, Eapen RS,
Hirayama-Yamada K, Joo K, et al: GATA4 mutations cause human
congenital heart defects and reveal an interaction with TBX5.
Nature. 424:443–447. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yang YQ, Gharibeh L, Li RG, Xin YF, Wang
J, Liu ZM, Qiu XB, Xu YJ, Xu L, Qu XK, et al: GATA4
loss-of-function mutations underlie familial tetralogy of Fallot.
Hum Mutat. 34:1662–1671. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Xiang R, Fan LL, Huang H, Cao BB, Li XP,
Peng DQ and Xia K: A novel mutation of GATA4 (K319E) is responsible
for familial atrial septal defect and pulmonary valve stenosis.
Gene. 534:320–323. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei D, Bao H, Liu XY, Zhou N, Wang Q, Li
RG, Xu YJ and Yang YQ: GATA5 loss-of-function mutations underlie
tetralogy of fallot. Int J Med Sci. 10:34–42. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wei D, Bao H, Zhou N, Zheng GF, Liu XY and
Yang YQ: GATA5 loss-of-function mutation responsible for the
congenital ventriculoseptal defect. Pediatr Cardiol. 34:504–511.
2013. View Article : Google Scholar
|
|
26
|
Shi LM, Tao JW, Qiu XB, Wang J, Yuan F, Xu
L, Liu H, Li RG, Xu YJ, Wang Q, et al: GATA5 loss-of-function
mutations associated with congenital bicuspid aortic valve. Int J
Mol Med. 33:1219–1226. 2014.PubMed/NCBI
|
|
27
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: Somatic GATA5 mutations in sporadic tetralogy of Fallot. Int J
Mol Med. 33:1227–1235. 2014.PubMed/NCBI
|
|
28
|
Wang X, Ji W, Wang J, Zhao P, Guo Y, Xu R,
Chen S and Sun K: Identification of two novel GATA6 mutations in
patients with nonsyndromic conotruncal heart defects. Mol Med Rep.
10:743–748. 2014.PubMed/NCBI
|
|
29
|
Huang RT, Xue S, Xu YJ and Yang YQ:
Somatic mutations in the GATA6 gene underlie sporadic tetralogy of
Fallot. Int J Mol Med. 31:51–58. 2013.
|
|
30
|
Baban A, Postma AV, Marini M, Trocchio G,
Santilli A, Pelegrini M, Sirleto P, Lerone M, Albanese SB, Barnett
P, et al: Identification of TBX5 mutations in a series of 94
patients with tetralogy of Fallot. Am J Med Genet A.
164A:3100–3107. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Al-Qattan MM and Abou Al-Shaar H:
Molecular basis of the clinical features of Holt-Oram syndrome
resulting from missense and extended protein mutations of the TBX5
gene as well as TBX5 ntragenic duplications. Gene. 560:129–136.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Pan Y, Geng R, Zhou N, Zheng GF, Zhao H,
Wang J, Zhao CM, Qiu XB, Yang YQ and Liu XY: TBX20 loss-of-function
mutation contributes to double outlet right ventricle. Int J Mol
Med. 35:1058–1066. 2015.PubMed/NCBI
|
|
33
|
Andersen TA, Troelsen Kde L and Larsen LA:
Of mice and men: Molecular genetics of congenital heart disease.
Cell Mol Life Sci. 71:1327–1352. 2014. View Article : Google Scholar :
|
|
34
|
Huang RT, Xue S, Xu YJ, Zhou M and Yang
YQ: A novel NKX2.5 loss-of-function mutation responsible for
familial atrial fibrillation. Int J Mol Med. 31:1119–1126.
2013.PubMed/NCBI
|
|
35
|
Xie WH, Chang C, Xu YJ, Li RG, Qu XK, Fang
WY, Liu X and Yang YQ: Prevalence and spectrum of Nkx2.5 mutations
associated with idiopathic atrial fibrillation. Clinics (Sao
Paulo). 68:777–784. 2013. View Article : Google Scholar
|
|
36
|
Yu H, Xu JH, Song HM, Zhao L, Xu WJ, Wang
J, Li RG, Xu L, Jiang WF, Qiu XB, et al: Mutational spectrum of the
NKX2-5 gene in patients with lone atrial fibrillation. Int J Med
Sci. 11:554–563. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Perera JL, Johnson NM, Judge DP and
Crosson JE: Novel and highly lethal NKX2.5 missense mutation in a
family with sudden death and ventricular arrhythmia. Pediatr
Cardiol. 35:1206–1212. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang XH, Huang CX, Wang Q, Li RG, Xu YJ,
Liu X, Fang WY and Yang YQ: A novel GATA5 loss-of-function mutation
underlies lone atrial fibrillation. Int J Mol Med. 31:43–50.
2013.
|
|
39
|
Postma AV, van de Meerakker JB, Mathijssen
IB, Barnett P, Christoffels VM, Ilgun A, Lam J, Wilde AA, Lekanne
Deprez RH and Moorman AF: A gain-of-function TBX5 mutation is
associated with atypical Holt-Oram syndrome and paroxysmal atrial
fibrillation. Circ Res. 102:1433–1442. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Hong K and Xiong Q: Genetic basis of
atrial fibrillation. Curr Opin Cardiol. 29:220–226. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Costa MW, Guo G, Wolstein O, Vale M,
Castro ML, Wang L, Otway R, Riek P, Cochrane N, Furtado M, et al:
Functional characterization of a novel mutation in NKX2-5
associated with congenital heart disease and adult-onset
cardiomyopathy. Circ Cardiovasc Genet. 6:238–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yuan F, Qiu XB, Li RG, Qu XK, Wang J, Xu
YJ, Liu X, Fang WY, Yang YQ and Liao DN: A novel NKX2-5
loss-of-function mutation predisposes to familial dilated
cardiomyopathy and arrhythmias. Int J Mol Med. 35:478–486.
2015.
|
|
43
|
Li RG, Li L, Qiu XB, Yuan F, Xu L, Li X,
Xu YJ, Jiang WF, Jiang JQ, Liu X, et al: GATA4 loss-of-function
mutation underlies familial dilated cardiomyopathy. Biochem Biophys
Res Commun. 439:591–596. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Zhao L, Xu JH, Xu WJ, Yu H, Wang Q, Zheng
HZ, Jiang WF, Jiang JF and Yang YQ: A novel GATA4 loss-of-function
mutation responsible for familial dilated cardiomyopathy. Int J Mol
Med. 33:654–660. 2014.
|
|
45
|
Li J, Liu WD, Yang ZL, Yuan F, Xu L, Li RG
and Yang YQ: Prevalence and spectrum of GATA4 mutations associated
with sporadic dilated cardiomyopathy. Gene. 548:174–181. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zhang XL, Dai N, Tang K, Chen YQ, Chen W,
Wang J, Zhao CM, Yuan F, Qiu XB, Qu XK, et al: GATA5
loss-of-function mutation in familial dilated cardiomyopathy. Int J
Mol Med. 35:763–770. 2015.
|
|
47
|
Xu L, Zhao L, Yuan F, Jiang WF, Liu H, Li
RG, Xu YJ, Zhang M, Fang WY, Qu XK, et al: GATA6 loss-of-function
mutations contribute to familial dilated cardiomyopathy. Int J Mol
Med. 34:1315–1322. 2014.PubMed/NCBI
|
|
48
|
Zhang XL, Qiu XB, Yuan F, Wang J, Zhao CM,
Li RG, Xu L, Xu YJ, Shi HY, Hou XM, et al: TBX5 loss-of-function
mutation contributes to familial dilated cardiomyopathy. Biochem
Biophys Res Commun. 459:166–171. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhou W, Zhao L, Jiang JQ, Jiang WF, Yang
YQ and Qiu XB: A novel TBX5 loss-of-function mutation associated
with sporadic dilated cardiomyopathy. Int J Mol Med. 36:282–288.
2015.PubMed/NCBI
|
|
50
|
Akazawa H and Komuro I: Cardiac
transcription factor Csx/Nkx2-5: Its role in cardiac development
and diseases. Pharmacol Ther. 107:252–268. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Kervestin S and Jacobson A: NMD: A
multifaceted response to premature translational termination. Nat
Rev Mol Cell Biol. 13:700–712. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Keeling KM and Bedwell DM: Suppression of
nonsense mutations as a therapeutic approach to treat genetic
diseases. Wiley Interdiscip Rev RNA. 2:837–852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kirk EP, Sunde M, Costa MW, Rankin SA,
Wolstein O, Castro ML, Butler TL, Hyun C, Guo G, Otway R, et al:
Mutations in cardiac T-box factor gene TBX20 are associated with
diverse cardiac pathologies, including defects of septation and
valvulogenesis and cardiomyopathy. Am J Hum Genet. 81:280–291.
2007. View
Article : Google Scholar : PubMed/NCBI
|
|
54
|
Qian L, Mohapatra B, Akasaka T, Liu J,
Ocorr K, Towbin JA and Bodmer R: Transcription factor
neuromancer/TBX20 is required for cardiac function in Drosophila
with implications for human heart disease. Proc Natl Acad Sci USA.
105:19833–19838. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Zhao CM, Bing-Sun, Song HM, Wang J, Xu WJ,
Jiang JF, Qiu XB, Yuan F, Xu JH and Yang YQ: TBX20 loss-of-function
mutation associated with familial dilated cardiomyopathy. Clin Chem
Lab Med. 54:325–332. 2016. View Article : Google Scholar
|
|
56
|
Shen T, Aneas I, Sakabe N, Dirschinger RJ,
Wang G, Smemo S, Westlund JM, Cheng H, Dalton N, Gu Y, et al: Tbx20
regulates a genetic program essential to adult mouse cardiomyocyte
function. J Clin Invest. 121:4640–4654. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Shen T, Yang C, Ding L, Zhu Y, Ruan Y,
Cheng H, Qin W, Huang X, Zhang H, Man Y, et al: Tbx20 functions as
an important regulator of estrogen-mediated cardiomyocyte
protection during oxidative stress. Int J Cardiol. 168:3704–3714.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Liu C, Shen A, Li X, Jiao W, Zhang X and
Li Z: T-box transcription factor TBX20 mutations in Chinese
patients with congenital heart disease. Eur J Med Genet.
51:580–587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Posch MG, Gramlich M, Sunde M, Schmitt KR,
Lee SH, Richter S, Kersten A, Perrot A, Panek AN, Al Khatib IH, et
al: A gain-of-function TBX20 mutation causes congenital atrial
septal defects, patent foramen ovale and cardiac valve defects. J
Med Genet. 47:230–235. 2010. View Article : Google Scholar :
|
|
60
|
Liu JJ, Fan LL, Chen JL, Tan ZP and Yang
YF: A novel variant in TBX20 (p.D176N) identified by whole-exome
sequencing in combination with a congenital heart disease related
gene filter is associated with familial atrial septal defect. J
Zhejiang Univ Sci B. 15:830–837. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Monroy-Muñoz IE, Pérez-Hernández N,
Rodríguez-Pérez JM, Muñoz-Medina JE, Angeles-Martínez J,
García-Trejo JJ, Morales-Ríos E, Massó F, Sandoval-Jones JP,
Cervantes-Salazar J, et al: Novel mutations in the transcriptional
activator domain of the human TBX20 in patients with atrial septal
defect. Biomed Res Int. 2015:7187862015. View Article : Google Scholar : PubMed/NCBI
|
